Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses
暂无分享,去创建一个
[1] S. Elberg,et al. Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles , 1994, Antimicrobial Agents and Chemotherapy.
[2] G. Lopez-Berestein,et al. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins , 1993, Antimicrobial Agents and Chemotherapy.
[3] A. Bangham. Liposomes: realizing their promise. , 1992, Hospital practice.
[4] P. Legrand,et al. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes , 1992, Antimicrobial Agents and Chemotherapy.
[5] J. Barwicz,et al. Effects of the aggregation state of amphotericin B on its toxicity to mice , 1992, Antimicrobial Agents and Chemotherapy.
[6] J. Bolard,et al. In vitro models for studying toxicity of antifungal agents , 1992, Antimicrobial Agents and Chemotherapy.
[7] M. C. Popescu,et al. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. , 1992, Biochimica et biophysica acta.
[8] G. Mandell,et al. Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro , 1992, Antimicrobial Agents and Chemotherapy.
[9] D. Lasič. Mixed micelles in drug delivery , 1992, Nature.
[10] T. Walsh,et al. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. , 1992, Drugs.
[11] A. Janoff. Lipids, liposomes, and rational drug design. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[12] D. Lasič,et al. Novel antifungal drug delivery: stable amphotericin B-cholesteryl sulfate discs , 1991 .
[13] F. Heitz,et al. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. , 1991, Biochemistry.
[14] S. Schreier,et al. Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering. , 1991, Journal of pharmaceutical sciences.
[15] G. Medoff,et al. Inhibition of Amphotericin B (Fungizone) Toxicity to Cells by Egg Lecithin-Glycocholic Acid Mixed Micelles , 1990, Antimicrobial Agents and Chemotherapy.
[16] H. Gallis,et al. Amphotericin B: 30 years of clinical experience. , 1990, Reviews of infectious diseases.
[17] J. Bolard,et al. Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations. , 1990, Biochimica et biophysica acta.
[18] M. Seman,et al. Interaction of amphotericin B and its N-fructosyl derivative with murine thymocytes: a comparative study using fluorescent membrane probes. , 1989, Biochimica et biophysica acta.
[19] S. Schreier,et al. Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study. , 1989, Biochimica et biophysica acta.
[20] J. Bolard,et al. Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids , 1989, Antimicrobial Agents and Chemotherapy.
[21] T. Patterson,et al. The role of liposomal amphotericin B in the treatment of systemic fungal infections. , 1989, European journal of cancer & clinical oncology.
[22] G. Lopez-Berestein. Liposomes as Carriers of Antifungal Drugs , 1988, Annals of the New York Academy of Sciences.
[23] J. Bolard,et al. Circular dichroism for the determination of amphotericin B binding to liposomes. , 1988, Analytical biochemistry.
[24] G. Medoff,et al. Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits , 1985, Antimicrobial Agents and Chemotherapy.
[25] D. Schlessinger,et al. Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B , 1985, Antimicrobial Agents and Chemotherapy.
[26] D. Schlessinger,et al. Stimulatory, permeabilizing, and toxic effects of amphotericin B on L cells , 1984, Antimicrobial Agents and Chemotherapy.
[27] D. Schlessinger,et al. Interaction of plasma proteins and lipoproteins with amphotericin B. , 1984, The Journal of infectious diseases.
[28] L. Gray,et al. Structure of amphotericin B aggregates based on calculations of optical spectra , 1983 .
[29] J. Grange,et al. Structure of amphotericin B aggregates as revealed by UV and CD spectroscopies , 1981 .
[30] J. Bolard,et al. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B: lipid state and cholesterol content dependence. , 1980, Biochimica et biophysica acta.